Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course

Session Description: 
This session explores the intricate interactions between novel cancer therapies and kidney function. Participants will gain a deeper understanding of the renal and electrolyte complications arising from new and emerging cancer treatments, including targeted therapies and immunotherapies. By analyzing real-world case studies and evidence-based practices, clinicians will be better equipped to recognize, manage, and mitigate these complications effectively. This session will also offer a comprehensive guide for establishing and operating an onconephrology clinic, as well as best practices for interdisciplinary collaboration. 
Learning Objectives:
1. Identify the mechanisms by which novel cancer therapies can lead to renal complications, including AKI and electrolyte abnormalities, and review the common clinical presentations and diagnostic approaches.
2. Distinguish immune-related kidney injury from other etiologies of AKI in cancer patients and formulate an evidence-based approach for managing ICI-associated renal toxicity.
3. Outline the key considerations and steps for setting up an onconephrology clinic. Recognize the importance of interdisciplinary collaboration in managing onconephrology patients.